Skip to main content

Author: Bill Snyder

Goldenring’s gastrointestinal research contributions lauded

Mar. 23, 2023—Vanderbilt's James Goldenring, MD, PhD, has been honored by the American Gastroenterological Association for making significant contributions to understanding gastrointestinal disease.

Read more


Scientists resurrect a ‘dead’ antibody to study protein

Mar. 16, 2023—Vanderbilt was part of a multi-center team that resurrected a “dead antibody” to reveal the mysteries of cytochrome c, a versatile protein that is an essential part of the cell’s energy-generating capacity, and of life itself.

Read more


Cardiovascular research pioneer Inagami mourned

Mar. 16, 2023—Tadashi Inagami, PhD, DSc, Vanderbilt University Professor of Biochemistry, emeritus, who helped characterize the biochemical basis for hypertension, heart failure and vascular disease, died in Pittsburgh, Pennsylvania, March 13 after a brief illness. He was 92.

Read more


Ashcroft named to receive Vanderbilt Prize in Biomedical Science

Mar. 15, 2023—Professor Dame Frances Ashcroft, a British physiologist known internationally for her work on insulin secretion, Type 2 diabetes and neonatal diabetes, is the recipient of the 2023 Vanderbilt Prize in Biomedical Science.

Read more


Study finds RSV may evade vaccines via rapid mutation

Mar. 9, 2023—A Vanderbilt study concluded that RSV’s ability to mutate rapidly to escape detection by the body’s immune system makes it more challenging to design and develop vaccines that can stop it from spreading.

Read more


Study finds chronically disrupted sleep may increase risk for heart disease

Feb. 15, 2023—Vanderbilt research found that sleep irregularity — chronically disrupted sleep and highly variable sleep durations night after night — may increase the risk for atherosclerosis.

Read more


Team’s imaging strategy enhances lipedema treatment

Feb. 9, 2023—A collaborative team at Vanderbilt is transforming the diagnosis and treatment of lipedema, a debilitating, abnormal deposition of fatty tissue that afflicts an estimated 17 million women in the United States.

Read more


VUMC’s ‘Shed-MEDS’ protocol can reduce risk of drug interactions in older people

Feb. 6, 2023—Vanderbilt University Medical Center's ‘Shed-MEDS’ protocol may reduce risk drug-drug interactions in older peole.

Read more


Researchers clarify role of blood cell mutations in disease

Feb. 2, 2023—Vanderbilt researchers have developed a new method to analyze mutations in blood stem cells that can trigger explosive, clonal expansions of abnormal cells.

Read more


Discovery of “cross-reactive” antibodies could aid treatment of viral co-infections

Feb. 2, 2023—  by Bill Snyder More than a million people in the United States are living with HIV, the virus that causes AIDS. One-fifth of them have been co-infected by the hepatitis C virus (HCV), which attacks the liver. Curative drugs for HCV are available, but many people don’t know they’ve been infected. And if they...

Read more


Nobel laureate Nurse set for year’s first Discovery Lecture

Jan. 26, 2023—Nobel Prize-winning geneticist and cell biologist Sir Paul Nurse, PhD, will be at Vanderbilt Thursday, Feb. 9, to deliver the year's first Discovery Lecture.

Read more


Study reveals new genetic disorder that causes susceptibility to opportunistic infections

Jan. 20, 2023—An international consortium co-led by Vanderbilt's Rubén Martínez-Barricarte, PhD, has discovered a new genetic disorder that causes immunodeficiency and profound susceptibility to opportunistic infections including a life-threatening fungal pneumonia. 

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more